Market revenue in 2023 | USD 170.5 million |
Market revenue in 2030 | USD 243.9 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Endocrinology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.74% in 2023. Horizon Databook has segmented the UAE home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE is the one of the countries with the lowest percentage of geriatric population worldwide. According to World Bank Group, the country’s population aged 65 & above accounted for nearly 1.0% of the total population in 2017 and around 1.2% in 2019. The low percentage of elderly population may negatively impact the need for home infusion therapies in the country. Obesity-related cardiovascular diseases is a major concern in the country. It was responsible for 27% of the total deaths, followed by diabetes, in 2017.
In 2018, according to Gulf International Cancer Centre, the total number of cancer cases in the UAE was 4,700, with colon cancer having the highest prevalence. High prevalence of chronic diseases is anticipated to fuel the market growth. Presence of major home care service providers, such as Manzil Healthcare Services, Americare Home Health Services, and Emirati Canadian Home Healthcare Services, is also anticipated to fuel the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into UAE home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account